Solid Tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years; 2. Diagnosed with a solid malignant tumor by histopathology; 3. Has officially signed the informed consent form and entered the clinical trial treatment phase, and is able to complete at least six cycles of treatment as required by the clinical trial protocol; 4. Clear consciousness, possesses basic communication skills, and can understand and complete questionnaires and interviews; 5. Voluntarily participates in this study and signs the informed consent form specifically for this research.
Exclusion criteria
Exclusion criteria: 1. The condition is critical and unable to endure participation; 2. Presence of mental illness or cognitive impairment prevents cooperation with completing the questionnaire; 3. Severe visual or hearing impairment, or communication disorders, assessed as unable to complete the survey; 4. Individuals who refuse to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| financial toxicity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Medical coping styles; | — |
Countries
China
Contacts
The First Affiliated Hospital with Nanjing Medical University